Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2025
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
Date | Total number of shares | Total number of voting rights |
| 04/30/2025 | 136,948,872 | Total gross of voting rights: 136,948,872 |
Total net* of voting rights: 136,762,549 |
* Net total = total number of voting rights attached to shares – shares without voting rights
| Last Trade: | US$12.91 |
| Daily Volume: | 0 |
| Market Cap: | US$463.930M |
November 11, 2025 October 28, 2025 October 06, 2025 | |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
